Many neurological abnormalities have been described in systemic lupus erythematosus (SLE), but transient bilateral ptosis and parkinsonism are rarely encountered. This paper describes a young Malay girl with SLE who develops psychosis, bilateral ptosis and parkinsonism during an exacerbation of her illness. These neurological features disappeared after adequate treatment with cyclophosphamide. Though the pathogenesis of these neurological abnormalities is not clearly known, it is likely that transient bilateral ptosis is due to myoneural dysfunction not unlike that of myasthenia gravis. As for parkinsonism, it can probably be explained on the basis of 'vasculitis' of the basal ganglia leading to microinfarcts and encephalomalacia. SYSTEMIC For the next 20 months, she was well while maintained on prednisolone 15 mg/day except on two occasions she had recurrence of fever when her prednisolone was reduced to 5 mg/day. On the twenty-first month, patient was readmitted because of abnormal behaviour, restlessness and wandering about aimlessly at night. Except for her prednisolone which she took faithfully 5 mg three times a day, there was no history of taking any other drugs. On clinical examination she was found to be disorientated and very careless in her dress and look. She exhibited frank paranoid thought and behaviour and was obviously psychotic. Careful neurological examination revealed bilateral ptosis (Fig. 1) As the psychosis came on after 20 months of prednisolone therapy the possibility of it being steroid-induced was considered. She was taken off her prednisolone, but no improvement was noted after 2 weeks. Therefore we considered at this stage that the psychosis, bilateral ptosis and parkinsonism were the result of the exacerbation of her SLE. Prednisolone was restarted at 60 mg/day and about 1 week later oral cyclophosphamide 100 mg/day was added. Improvement of her symptoms became noticeable only during the second week after cyclophosphamide was added. At that time prednisolone was gradually reduced in its dosage. One month later, features of parkinsonism and bilateral ptosis disappeared (Fig.  2) . As for her psychosis, the improvement was slow but steady. It took about 2 months before we could convince ourselves that she had completely recovered. By then the patient was only on cyclophos- phamide and the side effect was obvious as her alopecia was marked and at one stage leucopenia severe. She was taken off the cyclophosphamide temporarily and was restarted at 50 mg/day with lesser side effects.
SYSTEMIC lupus erythematosus (SLE) is a generalized condition affecting the connective tissues of many organs. Though it affects particularly the skin and joints, it can have many forms of presentations and sometimes the disorder of single system may dominate the picture. Symptoms referable to central nervous system are commonly found in SLE and can occasionally be the presenting features. In a recent large prospective study of SLE, Estes and Christian (1971) observed that central nervous system involvement was found in 59 % of patients. The symptoms may vary from neurosis to psychosis. Convulsive seizures of any type can occur. In addition peripheral neuropathy, cranial nerve disorders, paralysis like hemiplegia, quadraplegia and paraplegia, chorea and myasthenia gravis have often been reported. In this paper, we report a case of SLE with two very unusual features: transient bilateral ptosis and parkinsonism. As the psychosis came on after 20 months of prednisolone therapy the possibility of it being steroid-induced was considered. She was taken off her prednisolone, but no improvement was noted after 2 weeks. Therefore we considered at this stage that the psychosis, bilateral ptosis and parkinsonism were the result of the exacerbation of her SLE. Prednisolone was restarted at 60 mg/day and about 1 week later oral cyclophosphamide 100 mg/day was added. Improvement of her symptoms became noticeable only during the second week after cyclophosphamide was added. At that time prednisolone was gradually reduced in its dosage. One month later, features of parkinsonism and bilateral ptosis disappeared (Fig.  2) . As for her psychosis, the improvement was slow but steady. It took about 2 months before we could convince ourselves that she had completely recovered. By then the patient was only on cyclophos- phamide and the side effect was obvious as her alopecia was marked and at one stage leucopenia severe. She was taken off the cyclophosphamide temporarily and was restarted at 50 mg/day with lesser side effects.
Discussion
The diagnosis of systemic lupus erythematosus in this young girl is clearly established by the findings of LE cells and positive antinuclear factor on many occasions in spite of the fact that ESR remains low. This therefore confirms the belief that it is not necessary for all patients with systemic lupus erythematosus to have elevated ESR as Dubois (1966) (Rowe, 1963 We have no doubt that our patient under study had clinical features of parkinsonism and they disappeared 1 month after treatment with cyclophosphamide. As we realized, parkinsonism could be induced by many drugs especially those of phenothiazines group which might be used by our patient for the treatment of her psychosis prior to her admission into the hospital, a very careful drug history was taken and there was no evidence to suggest that her parkinsonism was drug-induced. Though parkinsonism is an extremely uncommon neurological manifestation of systemic lupus erythematosus, there is no reason to believe that this cannot occur. Dubois (1966) was always impressed by the different presenting neurological features and the extreme variability of the central nervous system changes which might occur in SLE. He believed that no part of the central nervous system was immune from the attack. The etiological diagnosis of any neurological presentation depended upon proving the presence of other conditions which might produce similar neurological changes. In our patient reported above, the presence of SLE is proven and we are unable to elicit any other cause for her parkinsonism. We have ruled out drug, carbon monoxide and manganese poisoning as the cause. Idiopathic parkinsonism is almost unheard of in this age group. Postencephalitic parkinsonism is unlikely as there is no past history of encephalitis and rapid improvement of her parkinsonism features makes it most unlikely.
The basic pathological lesion of many neurological changes is the 'vasculitis' leading to haemorrhages, microinfarcts, perivascular fibrosis and encephalomalacia in the nervous system (Johnson, 1962; Johnson and Richardson, 1968) . The autopsy finding of encephalomalacia in the basal ganglia in Willoughby's patient with cogwheel rigidity supports our belief that parkinsonism can be caused by 'vasculitis' in the corpus striatum particularly globus pallidus and substantia nigra. As chorea, another disorder of corpus striatum particularly the caudate necleus, is not too uncommonly associated with SLE (Paradise, 1960) , it is therefore surprising to find that parkinsonism is so uncommon in patients with systemic lupus erythematosus. Summary Thirty-one patients with aplastic anaemia were treated with oxymetholone. Twenty-eight patients lived beyond 2 months and of these eleven patients showed clinical and haematological improvement. Ten of these had some active erythropoietic areas as shown by bone marrow biopsies and by the presence of an elevated reticulocyte count in the peripheral blood. Two patients who responded in spite of a markedly hypoplastic marrow and reticulocytopenia became oxymetholone dependent and relapsed when the drug was withdrawn. They failed to respond a second time when oxymetholone was re-introduced. Side effects were frequent. These were mostly tolerable and reversible on reduction of the dose but three patients died of acute myeloblastic leukaemia and in three others the drug had to be withdrawn. DURING recent years androgenic hormones have been used extensively in aplastic anaemia (Shahidi and Diamond, 1961; Sanchez-Medal et al., 1964; Reynafarje and Faura, 1967; Daiber et al., 1970 Allen et al. (1968) and by Silink and Firkin (1968) .
We present here our experience with oxymetholone on thirty-one patients with aplastic anaemia.
Patients and methods
Thirty-one patients were treated. All had pancytopenia and a marrow with reduced cellularity at some stage on serial trephine biopsies. In nine patients aplastic anaemia was considered to be drug-induced (Table 1 Haematological investigation and ferrokinetic studies were performed by standard methods (Dacie and Lewis, 1968) . All patients had a sternal marrow aspiration and a trephine biopsy on the iliac crest. Both these procedures were repeated on seventeen patients to define the extent of aplasia and to assess the response to therapy. Sixteen patients died and autopsies were performed on nine. In these patients sections from the pelvis and from the vertebral column were examined histologically to get an overall picture of the marrow cellularity. Marrow cellularity was divided into the following sub-headings according to the observations made on the trephine sections:
(a) Marked hypoplasia. The trephine sections showed an occasional collection of lymphocytes or reticulum cells among the fatty cells. There was a severe depression of the erythro-myeloid elements and a complete absence of megakaryocytes.
(b) Moderate hypoplasia. A marked reduction of the overall cellularity but an occasional island of
